Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Inovio (INO) Soars 19.0%: Is Further Upside Left in the Stock?
10:31am, Friday, 12'th Jul 2024
Inovio (INO) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in th
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway
08:00am, Thursday, 11'th Jul 2024
Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering from Recurrent Respiratory Papillomatosis (RRP) PLYMOUTH MEETING, Pa. , July
INOVIO Announces Appointment of Steven Egge as Chief Commercial Officer
04:05pm, Tuesday, 02'nd Jul 2024
Mr. Egge brings over 25 years of biopharmaceutical experience building commercial organizations and successfully launching novel therapeutic products INOVIO poised to become a commercial-stage company
INOVIO Reports Inducement Grant Under Inducement Plan
04:00pm, Monday, 01'st Jul 2024
PLYMOUTH MEETING, Pa. , July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-rel
INOVIO Added to Russell 2000® Index Effective July 1, 2024
08:00am, Monday, 01'st Jul 2024
PLYMOUTH MEETING, Pa. , July 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-as
INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.
08:00am, Tuesday, 04'th Jun 2024
PLYMOUTH MEETING, Pa. , June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-ass
INOVIO Reports Inducement Grants Under Inducement Plan
04:48pm, Friday, 31'st May 2024
PLYMOUTH MEETING, Pa. , May 31, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
Better Buy: Inovio Pharmaceuticals vs. Novavax
09:45am, Wednesday, 22'nd May 2024
Novavax just signed a lucrative agreement with a biotech giant. Inovio Pharmaceuticals is inching closer to launching its leading candidate.
Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 2nd Annual BioConnect Investor Conference (Transcript)
04:31pm, Monday, 20'th May 2024
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) H.C. Wainwright 2nd Annual BioConnect Investor Conference Call May 20, 2024 12:30 PM ET Company Participants Jacqueline Shea - President & Chief Executive Of
Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)
02:15pm, Wednesday, 15'th May 2024
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) RBC Capital Markets Global Healthcare Conference May 15, 2024 10:00 AM ET Company Participants Jacqueline Shea - CEO Mike Sumner - Chief Medical Officer Conf
Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)
04:44pm, Tuesday, 14'th May 2024
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) The Citizens JMP Life Sciences Conference May 14, 2024 11:30 AM ET Company Participants Jacqueline Shea - CEO Conference Call Participants Roy Buchanan - Cit
Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript
07:47pm, Monday, 13'th May 2024
Inovio Pharmaceuticals, Inc. (NASDAQ:INO ) Q1 2024 Earnings Conference Call May 13, 2024 4:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacqueline Shea - President and Chi
INOVIO Reports First Quarter 2024 Financial Results and Recent Business Highlights
04:05pm, Monday, 13'th May 2024
BLA submission on track for INO-3107 in second half of 2024; if approved under accelerated approval pathway, could be first non-surgical treatment for recurrent respiratory papillomatosis (RRP) Planni
This Under-the-Radar Stock Is Up by 96% This Year: Time to Buy?
08:54am, Sunday, 05'th May 2024
Inovio Pharmaceuticals' former two leading candidates both fell flat. The company is seeking approval for another product following positive clinical results.
INOVIO Reports Inducement Grants Under Inducement Plan
08:00am, Wednesday, 01'st May 2024
PLYMOUTH MEETING, Pa. , May 1, 2024 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-re
